AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On June 20, 2025,
, Inc. (MRK) experienced a significant decline in its stock price, dropping by 0.21%. The trading volume for the day was substantial, with a total of 10.35 billion shares exchanged, placing it at the 72nd position in terms of trading volume for the day.Analysts have provided a mixed outlook for Merck's stock. According to 15 analysts, the average rating for
stock is "Buy." The 12-month stock price forecast is $113.71, which represents an increase of 43.83% from the current price. The highest price target for MRK is $140.00, while the lowest is $84.00. The average price target suggests a forecasted upside of 37.53%.Recent changes in analyst ratings have also impacted investor sentiment. On January 8, 2025, Truist downgraded
from "Buy" to "Hold" with a price target of $110. Similarly, on December 20, 2024, BMO Capital Markets downgraded the stock from "Outperform" to "Market Perform," adjusting the price target from $136 to $105.Technical analysis indicates that Merck's stock has a MACD of 0.44 and an RSI of 52.38, suggesting a neutral to slightly bullish trend. The stock is expected to hit a high point of $128.39 in May and reach a low of $108.91 in October, with an overall average trading price throughout the year.
Hunt down the stocks with explosive trading volume.

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet